AbbVie

AbbVie is a research-based biopharmaceutical company.

AbbVie began as the pharmaceutical leader, Abbott, which was founded in 1888 by Chicago physician, Dr. Wallace Abbott. In 2011 the companines split into Abbott and AbbVie. On January 1, 2013, AbbVie was founded as a global biopharmaceutical company with 'focus and capabilities to address some of the world’s greatest health challenges'.

Staff

Board of Directors

• Richard A. Gonzalez
• Robert J. Alpern
• Roxanne S. Austin
• William H.L. Burnside
• Edward M. Liddy
• Edward J. Rapp
• Roy S. Roberts
• Glenn F. Tilton
• Frederick H. Waddell

AbbVie Leadership

• RIchard A. Gonzalez - Chairman of the Board and chief executive officer
• Laura J. Schumacher - Executive vice president, business development, external affairs and general counsel
• William J. Chase - Executive vice president, chief financial officer
• Carlos Alban - Executive vice president, commercial operations
• Michael E. Severino - Executive vice president, research & development and chief scientific officer
• Timothy J. Richmond - Senior vice president, human resources
• Azita Saleki- Gerhardt - Senior vice president, operations
• Karen Hale - Vice president, chief ethics and compliance officer

• Tony Sampson - Director of government affairs

Affiliations

AbbVie is a donor to the Science Media Centre.

• The Corporate Capture of the NHS

Lobbying firms

• Luther Pendragon
• JMC Partners LLP

Contact

Web site: www.abbvie.co.uk Address: AbbVie Ltd, Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4XE, UK

Resources

See: The Corporate Capture of the NHS

• Tamasin Cave, The privatising cabal at the heart of our NHS Spinwatch, 1 April 2015.